Francesco Manti
Catanzaro, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remission.
Journal: Frontiers in pharmacology
Published: November 30, 2025
Quantification and Analysis of Lung Involvement by Artificial Intelligence in Patients with Progressive Pulmonary Fibrosis Treated with Nintedanib.
Journal: Medicina (Kaunas, Lithuania)
Published: August 01, 2025
Deep Learning-Based 3D and 2D Approaches for Skeletal Muscle Segmentation on Low-Dose CT Images.
Journal: Journal of imaging informatics in medicine
Published: June 02, 2025
Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation.
Journal: Journal of clinical medicine
Published: May 21, 2025
Pituitary enlargement and hypopituitarism in patient with lung cancer treated with immune checkpoint inhibitors: Metastasis or hypophysitis? Role of imaging.
Journal: Radiology case reports
Published: November 01, 2024
Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome.
Journal: Journal of clinical medicine
Published: April 16, 2024
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome.
Journal: Journal of translational medicine
Published: March 14, 2024
Insect and spider biodiversity: A dataset of mountainous wetland sites in Aspromonte National Park (Calabria, southern Italy).
Journal: Data in brief
Published: February 22, 2024
Cholecystocolonic fistula in exacerbated chronic cholecystitis: A case report.
Journal: Radiology case reports
Published: August 02, 2023
Impact of the COVID-19 pandemic and COVID vaccination campaign on imaging case volumes and medicolegal aspects.
Journal: Frontiers in health services
Published: July 11, 2023
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
Journal: Journal of hematology & oncology
Published: December 25, 2022
Last Updated: 09/26/2026